• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 ULTRA RESILIA TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 ULTRA RESILIA TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9755RSL29A
Device Problem Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/25/2024
Event Type  malfunction  
Event Description
Edwards received notification from a field clinical specialist that a patient underwent a transfemoral tavr.As reported, the valve strut bent backwards in esheath during advancement.There was no resistance between the valve/ds and the esheath noted.The device was removed.A second device was prepped and implanted successfully.There was damage noted on the 1st esheath.It was split/pierced at the distal tip.There were no patient injuries.
 
Manufacturer Narrative
The investigation is in progress.A supplemental report will be submitted.This is one of two manufacturer reports being submitted for this case.Please reference related manufacturer report no: 2015691-2024-01123.
 
Manufacturer Narrative
The device was returned for evaluation and an engineering evaluation was performed.The returned device was visually examined for any abnormalities and the following was observed.Crimped valve: one (1) strut bent on the inflow side.Three (3) struts exposed through skirt, normal after manipulation during insertion through sheath.Expanded valve: one (1) strut remains bent.Three (3) struts remain exposed through skirt.Frame is canted and deformed.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The complaint of valve frame damage was confirmed based on evaluation of the returned device and imagery.A review of the dhr, lot history, and complaint history did not provide any indication that a manufacturing non-conformance contributed to the complaint event.A review of ifu/training materials revealed no deficiencies.As reported, ''the valve strut bent backwards in esheath during advancement''.Procedural fluoroscopy shows an inflow valve strut bent outwards within the sheath.Per the training manual, ''push force can vary due to angle of insertion, thv size, vessel diameter, tortuosity and degree of calcification'', ''if push force is high, consider slightly pulling back the sheath 1-2 cm while advancing the thv/delivery system'', and ''do not over-manipulate the sheath at any time''.Per 3mensio, the patient has calcification and tortuosity in the access vessels.Calcification and tortuosity can result in the creation of sub-optimal angles during delivery system insertion that may lead to increased interaction between the valve and the inner lumen of the sheath.In this case, excessive device manipulation or high push force can lead to the valve struts interacting with the sheath and result in the frame damage at the valve inflow side.As such, available information suggests that patient factors (calcification, tortuosity) and/or procedural factors (excessive device manipulation) may have contributed to the complaint event.No device or labeling problem was identified during the evaluation.Therefore, no further escalation is required.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS SAPIEN 3 ULTRA RESILIA TRANSCATHETER HEART VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key18723630
MDR Text Key336090114
Report Number2015691-2024-01124
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9755RSL29A
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/25/2024
Initial Date FDA Received02/16/2024
Supplement Dates Manufacturer Received05/07/2024
Supplement Dates FDA Received05/07/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured07/13/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexMale
-
-